Fecal microbiota transplantation for clostridium difficile infection: Systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 108, Issue 4, 2013, Pages 500-508

  Kassam, Zain ^a   Lee, Christine H ^b,c   Yuan, Yuhong ^a,d   Hunt, Richard H ^a,d  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DONOR; DONOR SELECTION; ENTERITIS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FECES MICROFLORA; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; STANDARD; SYSTEMATIC REVIEW; TRANSPLANTATION; UPPER GASTROINTESTINAL BLEEDING;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; METAGENOME; TREATMENT OUTCOME;

EID: 84875952542     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.59     Document Type: Review

References (59)

1. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-40.
2. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-9.
3. Vonberg RP, Reichardt C, Behnke M et al. Cost of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008; 70: 15-20.
4. Dubberke ER, Olsen MA. Burden of C lostridium difficile on the healthcare system. Clin Infect Dis 2012; 55 (Suppl 2): S88-92.
5. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
6. Pepin J, Saheb N, Coulombe MA et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41: 1254-60.
7. Petrella LA, Sambol SP, Cheknis A et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C difficile BI strain. Clin Infect Dis 2012; 55: 351-7.
8. Chang JY, Antonopoulos DA, Kalra A et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197: 435-8.
9. Khoruts A, Dicksved J, Jansson JK et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-60.
10. Eiseman B, Silen W, Bascom GS et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-9.
11. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011; 9: 88-96.
12. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15: 285-9.
13. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
14. Guo B, Harstall C, Louie T et al. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 865-75.
15. Bauer MP, Kuijper EJ, van Dissel JT et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009; 15: 1067-79.
16. Chambers D, Rodgers M, Woolacott N. Not only randomized controlled trials, but also case series should be considered in systematic reviews of rapidly developing technologies. J Clin Epidemiol 2009; 62: 1253-60.
17. Moga C, Guo B, Schopflocher D et al. Development of a quality appraisal tool for case series studies using a modified delphi technique. Inst HealThecon 2012; www.ihe.ca/documents/caseseriesstudiesusingamodifiedDelphiTechnique.pdf (accessed October 2012).
18. National Collaborating Centre for Acute Care. Preoperative tests: the use of routine tests for elective surgery: evidence, methods & guidance. National Institute for Clinical Excellence (NICE) 2003.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
20. Martin L. Modified fecal transplantation. J Clin Gastroenterol 2011; 45: 742.
21. Ho N, Prasad V. Clostridium difficile diarrhea and fecal transplantation. J Clin Gastroenerol 2011; 45: 742-3.
22. Rubin TA, Gessert CE, Aas J. Stool transplantation for older patients with Clostridium difficile. J Am Geriatr Soc 2009; 57: 2386.
23. Midtvedt K. Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 1998; 30:118: 1758.
24. Tvede M, Rask-Madsen J. Bacteriotherapy for Clostridium difficile diarrhea. Lancet 1990; 335: 110.
25. Wilson KH. Bacteriotherapy for Clostridium difficile colitis. Lancet 1989; 2: 1096.
26. Seal DV, Borriello SP, Piper M. Bacteriotherapy for Clostridium difficile diarrhoea. Lancet 1989; 2: 558.
27. Collins DC. Pseudomembranous enterocolitis. Further observations on the value of donor fecal enemata as an adjunct in the treatment of pseudomembranous enterocolitis. Am J Proctol 1960; 2: 389-91.
28. Wilcox GM. Early experience with Fecal Bacteriotherapy (FB) program for recurrent C difficile infection (CDI). Gastroenterology 2011; 140: S361.
29. Kassam Z, Hundal R, Marshall JK et al. Fecal transplantation via retention enemas is Effective for recurrent or refractory Clostridium difficile-associated diarrhea. Gastroenterology 2010; 138: S207-8.
30. Arkkila PE, Uusitalo-Seppala R, Lehtola L et al. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Gastroenterology 2010; 138: S5.
31. Keller JJ, Van Nood E, Speelman P et al. Antonie van Leeuwenhoek. 2009; 95: S40-1.
32. Hellemans R, Naegels S, Holvet J. Fecal transplantation for recurrent Clostridium difficile colitis, an underused treatment modality. Acta Gastroenterol Belg 2009; 72: 269-70.
33. Harkonen N. Recurrent pseudomembranous colitis treated with the donor feces. Duodecim 1996; 112: 1803-4.
34. Schwan A, Ajolin S, Trottestam U et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2: 845.
35. Grehan MJ, Torody TJ, Leis SM et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551-61.
36. Bowden TA, Mansberger AR, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981; 47: 178-83.
37. Mattila E, Uusitalo-Seppala R, Wuorela M et al. Fecal transplantation, through colonoscopy, is Effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-6.
38. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44: 567-70.
39. Mellow MH, Kanatzar A. Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection-results and follow up. J Okla State Med Assoc 2011; 104: 89-91.
40. Garborg K, Waagsbo B, Stallemo A et al. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857-61.
41. MacConnachie AA, Fox R, Kennedy DR et al. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 2009; 102: 781-4.
42. Lund-Tonnesen S, Berstad A, Schreiner A et al. Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 1998; 118: 1027-30.
43. Kelly CR, de Leon L, Jasutkar N et al. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46: 145-9.
44. Polak P, Freibergerova M, Jurankova J et al. First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile. Klin Mikrobiol Infekc Lek 2011; 17: 214-7.
45. Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol 2010; 44: 562-6.
46. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series of 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-5.
47. Kassam Z, Hundal R, Marshall JK et al. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012; 172: 191-3.
48. Zipursky JS, Sidorsky TI, Freeman CA et al. Patients attitudes towards the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012; Oct 22 (e-pub ahead of print).
49. Bakken JS, Borody T, Brandt LJ et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-9.
50. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-42.
51. Sartor RB. Microbial influences in inflammatory bowel disease. Gastroenterology 2008; 134: 577-94.
52. Piche T, Vanbiervliet G, Pipau FG et al. Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol 2007; 21: 727-31.
53. Dai C, Jiang M. The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis. Hepatogastroenterology 2012; 59: 67-72.
54. Petrof E, Gloor GB, Vanner S et al. RePOOPulating the gut: use of synthetic stool to cure recurrent C. difficile infection. Can J Gastroenterol 2012; A042.
55. van Nood E. The FECAL trial, fecal therapy to eliminate Clostridium difficile associated longstanding diarrohoea. Netherlands Trial Register. NTR Number 1177. http://www.trialregister.nl/trialreg/admin/rctview. asp?TC=1177 (accessed November 2012).
56. Lee CH, Petrof E. Multi-centre trial of fresh vs frozen-and-thawed HBT (Fecal Transplant) for recurrent CDI. U.S. National Institutes of Health Trial Register. NCT Number 01398969. http://www.clinicaltrials.gov/ct2/show/ NCT01398969?term=fecal+transplant & rank=2 (accessed October 2012).
57. Hota S. Oral vancomycin followed by fecal transplant vs. tapering oral vancomycin. U.S. National Institutes of Health Trial Register. NCT Number 01226992. http://www.clinicaltrials.gov/ct2/show/NCT01226992?term=feca l+transplant & rank=1 (accessed October 2012).
58. Kelly CR. Fecal transplant for relapsing C. difficile infection. U.S. National Institutes of Health Trial Register. NCT Number 01703494. http://www. clinicaltrials.gov/ct2/show/NCT01703494?term=fecal+transplant & rank=4 (accessed October 2012).
59. Cuzzolin L, Zambreri D, Donini M et al. Influence of radiotherapy on intestinal microflora in cancer patients. J Chemother 1992; 4: 176-9.